DING, Yangfeng; LIU, Weida. Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. Acta Dermato-Venereologica, [S. l.], v. 106, p. adv–2025, 2026. DOI: 10.2340/actadv.v106.adv-2025-0183. Disponível em: https://medicaljournalssweden.se/actadv/article/view/45950. Acesso em: 24 apr. 2026.